Terminé
Feasibility, tolerability, and efficacy of an interferon-free antiviral regimen combining sofosbuvir and ribavirin for the treatment of chronic hepatitis C genotype 2, and sofosbuvir and ledipasvir in the treatment of chronic hepatitis C genotypes 1 and 4 in Central and West Africa
Feasibility, tolerability, and efficacy of an interferon-free antiviral regimen combining sofosbuvir and ribavirin for the treatment of chronic hepatitis C genotype 2, and sofosbuvir and ledipasvir in the treatment of chronic hepatitis C genotypes 1 and 4 in Central and …
Project Details
Description & Context
Feasibility, tolerability, and efficacy of an interferon-free antiviral regimen combining sofosbuvir and ribavirin for the treatment of chronic hepatitis C genotype 2, and sofosbuvir and ledipasvir in the treatment of chronic hepatitis C genotypes 1 and 4 in Central and West Africa
Research Team
The research team has not yet been filled in for this project.
Collaborate with us
We are open to partnerships with international research institutions and doctoral students.
Research Request
Estimated response time: 3-5 business days.
Keywords
OUR PROJECTS
